Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02393859 |
|---|---|
| Brief Title: | Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL) |
| First Submitted : | March 16, 2015 |
| First Submitted that Met QC Criteria : | March 19, 2015 |
| First Posted : | March 20, 2015 (Estimate) |
| Results First Submitted : | June 24, 2020 |
| Results First Submitted that Met QC Criteria : | June 24, 2020 |
| Results First Posted : | July 13, 2020 |
| Last Update Submitted that Met QC Criteria : | February 15, 2024 |
| Last Update Posted : | February 21, 2024 |